Trial · NCT05594342
Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
NCT05594342, Phase 3, Unknown, The Young Investigator Group of Cardiovascular Research
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support. Trials, record NCT05594342. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05594342
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
- NCT number
- NCT05594342
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 200 participants, estimated
- Lead sponsor
- The Young Investigator Group of Cardiovascular Research
- Conditions
- Heart Failure, Cardiogenic Shock, Ischemic Heart Disease
- Interventions
- Ivabradine 7.5Mg Tab, DOBUTamine Injectable Solution
- First posted
- 2022-10-26
- Last updated
- 2022-10-26
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Heart rate reduction | Up to 7 days | Amount of reduction of heart rate calculated by subtracting the heart rate at the time of weaning from the initial heart rate |
| Primary | Time of weaning from dobutamine infusion | Up to 7 days | The time needed to completely wean dobutamine infusion calculated in hours |
| Primary | Duration of hospital stay | Up to 1 month | Total duration of hospital stay calculated in days |
| Secondary | Ventricular arrhythmias (Ventricular Tachycardia and/or Fibrillation) | Up to 1 month | Any ventricular arrhythmias will be documented |
| Secondary | Supraventricular arrhythmia | Up to 1 month | Any supraventricular arrhythmias will be documented |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05594342
GET https://conductscience.org/api/trials/v1/NCT05594342/registered